Homie Razavi

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 23

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Viruses

Journal of viral hepatitis

Hepatology (Baltimore, Md.)

Center for Disease Analysis Foundation

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Center for Disease Analysis Foundation Dec 01 2017

United States

Managing Director

Publications

Young Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee, Lewis Rowland Roberts, Homie Razavi, Patrick T F Kennedy
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses 15 (4) (2023)
Young Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee, Lewis Rowland Roberts, Homie Razavi, Patrick T F Kennedy
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses 15 (4) (2023)
Sameera Ezzat, Ivane Gamkrelidze, Alaa Osman, Asmaa I Gomaa, Ayat Roushdy, Gamal Esmat, Homie Razavi, Sarah Blach, Wael Abdel-Razek, Wafaa El-Akel, Imam Waked
Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost-effectiveness model. Liver international : official journal of the International Association for the Study of the Liver (2023)
Erkin Musabaev, Chris Estes, Shakhlo Sadirova, Shokhista Bakieva, Krestina Brigida, Rick Dunn, Shyamasundaran Kottilil, Poonam Mathur, Ameer Abutaleb, Kathryn Razavi-Shearer, Tim Anstiss, Bakhodir Yusupaliev, Homie Razavi
Viral hepatitis elimination challenges in low- and middle-income countries-Uzbekistan Hepatitis Elimination Program (UHEP). Liver international : official journal of the International Association for the Study of the Liver 43 (4) (2023)
Homie Razavi
Response to overcoming the challenges in eliminating viral hepatitis in low- and middle-income countries. Liver international : official journal of the International Association for the Study of the Liver (2023)
Erkin Musabaev, Chris Estes, Shakhlo Sadirova, Shokhista Bakieva, Krestina Brigida, Rick Dunn, Shyamasundaran Kottilil, Poonam Mathur, Ameer Abutaleb, Kathryn Razavi-Shearer, Tim Anstiss, Bakhodir Yusupaliev, Homie Razavi
Viral hepatitis elimination challenges in low- and middle-income countries-Uzbekistan Hepatitis Elimination Program (UHEP). Liver international : official journal of the International Association for the Study of the Liver 43 (4) (2023)
Young Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee, Lewis Rowland Roberts, Homie Razavi, Patrick T F Kennedy
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses 15 (4) (2023)
Erkin Musabaev, Chris Estes, Shakhlo Sadirova, Shokhista Bakieva, Krestina Brigida, Rick Dunn, Shyamasundaran Kottilil, Poonam Mathur, Ameer Abutaleb, Kathryn Razavi-Shearer, Tim Anstiss, Bakhodir Yusupaliev, Homie Razavi
Viral hepatitis elimination challenges in low- and middle-income countries-Uzbekistan Hepatitis Elimination Program (UHEP). Liver international : official journal of the International Association for the Study of the Liver 43 (4) (2023)
Young Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee, Lewis Rowland Roberts, Homie Razavi, Patrick T F Kennedy
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses 15 (4) (2023)
Erkin Musabaev, Chris Estes, Shakhlo Sadirova, Shokhista Bakieva, Krestina Brigida, Rick Dunn, Shyamasundaran Kottilil, Poonam Mathur, Ameer Abutaleb, Kathryn Razavi-Shearer, Tim Anstiss, Bakhodir Yusupaliev, Homie Razavi
Viral hepatitis elimination challenges in low- and middle-income countries-Uzbekistan Hepatitis Elimination Program (UHEP). Liver international : official journal of the International Association for the Study of the Liver (2023)
Homie Razavi
Polaris Observatory-supporting informed decision-making at the national, regional, and global levels to eliminate viral hepatitis. Antiviral therapy 27 (2) (2022)
David W Matthews, Samantha Coleman, Homie Razavi, Jean-Manuel Izaret
The Payer License Agreement, or "Netflix model," for hepatitis C virus therapies enables universal treatment access, lowers costs and incentivizes innovation and competition. Liver international : official journal of the International Association for the Study of the Liver 42 (7) (2022)
Ivane Gamkrelidze, Jean Michel Pawlotsky, Jeffrey Victor Lazarus, Jordan J Feld, Stefan Zeuzem, Yanjun Bao, Ana Gabriela Pires Dos Santos, Yuri Sanchez Gonzalez, Homie Razavi
Progress towards hepatitis C virus elimination in high-income countries: An updated analysis. Liver international : official journal of the International Association for the Study of the Liver 41 (3) (2021)
Homie Razavi
The cost-effectiveness of hepatitis C virus elimination in low- and middle-income countries. Journal of viral hepatitis 28 (2) (2020)
Homie Razavi, Yuri Sanchez Gonzalez, Cammy Yuen, Markus Cornberg
Response to Taiwan is on track of accelerating hepatitis C elimination by 2025. Liver international : official journal of the International Association for the Study of the Liver 40 (6) (2020)
Margaret J de Villiers, Ivane Gamkrelidze, Timothy B Hallett, Shevanthi Nayagam, Homie Razavi, Devin Razavi-Shearer
Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models. PloS one 15 (8) (2020)
Loreta Anesti Kondili, Ivane Gamkrelidze, Sarah Blach, Andrea Marcellusi, Massimo Galli, Salvatore Petta, Massimo Puoti, Stefano Vella, Homie Razavi, Loreta A Kondili, Francesco Saverio Mennini, null null
Optimization of hepatitis C virus screening strategies by birth cohort in Italy. Liver international : official journal of the International Association for the Study of the Liver 40 (7) (2020)
Chris Estes, Henry Lik Yuen Chan, Rong-Nan Chien, Wan-Long Chuang, James Yan-Yue Fung, George Boon-Bee Goh, Tsung-Hui Hu, Jee-Fu Huang, Byoung Kuk Jang, Dae Won Jun, Jia-Horng Kao, Young-Joo Jin, Han-Chieh Lin, Kathryn Razavi-Shearer, Wai Kay Seto, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Homie Razavi
Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply. Alimentary pharmacology & therapeutics 51 (12) (2020)
Angelos Hatzakis, Jeffrey Victor Lazarus, Evangelos Cholongitas, Ricardo Baptista-Leite, Charles Boucher, Cristian-Silviu Busoi, Sylvie Deuffic-Burban, Jagpreet Chhatwal, Gamal Esmat, Sharon Hutchinson, Minerva-Melpomeni Malliori, Mojca Maticic, Antons Mozalevskis, Francesco Negro, George A Papandreou, Georgios Papatheodoridis, Markus Peck-Radosavljevic, Homie Razavi, Tatjana Reic, Eberhard Schatz, Nurdan Tozun, Zobair M Younossi, Michael P Manns
Securing sustainable funding for viral hepatitis elimination plans. Liver international : official journal of the International Association for the Study of the Liver 40 (2) (2019)
Homie Razavi, Yuri Sanchez Gonzalez, Cammy Yuen, Markus Cornberg
Global timing of hepatitis C virus elimination in high-income countries. Liver international : official journal of the International Association for the Study of the Liver 40 (3) (2019)
Jason Grebely, Sarah Larney, Amy Peacock, Samantha Colledge-Frisby, Janni K Y Leung, Matthew Hickman, Peter Vickerman, Sarah Blach, Evan B Cunningham, Konstantin Dumchev, Michael T Nurmohamed, Jack Stone, Adam Trickey, Homie Razavi, Richard P Mattick, Michael Farrell, Gregory J Dore, Louisa Degenhardt
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction (Abingdon, England) 114 (1) (2018)
Jisoo A Kwon, Gregory J Dore, Jason Grebely, Behzad Hajarizadeh, Rebecca J Guy, Evan B Cunningham, Cherie Power, Chris Estes, Homie Razavi, Richard T Gray, null null
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study. Journal of viral hepatitis 26 (1) (2018)
Chris Estes, Homie Razavi, Rohit Loomba, Zobair M Younossi, Arun J Sanyal
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology (Baltimore, Md.) 67 (1) (2017)

Homie Razavi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Homie Razavi